Bruker Corporation revenue by segment BRKRP

Annual Quarterly

Bruker Corporation splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Bsi Calid at $1.2 billion, 35% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $2.8 billion, 81% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	3,513	3,436	3,366	2,964	2,531	2,418	1,988	2,073	1,896	1,766	1,611
Operating segments
Bsi Calid	—	1,210 +10.7% share 35.2%	1,094 +13.9% share 32.5%	960 +16.8% share 32.4%	822 share 32.5%	—	—	—	—	—	—
Bsi Nano	—	1,084 -1.3% share 31.6%	1,098 +16.6% share 32.6%	942 +19.7% share 31.8%	787 share 31.1%	—	—	—	—	—	—
Bsi Biospin	—	879 -3.0% share 25.6%	906 +13.4% share 26.9%	798 +14.6% share 26.9%	697 share 27.5%	—	—	—	—	—	—
Energy And Supercon Technologies	—	263 -2.1% share 7.7%	269 +2.0% share 8.0%	264 +17.3% share 8.9%	225 share 8.9%	—	—	210 +7.8% share 10.1%	195 share 10.3%	—	—
Sales mix
Product	2,799 +0.8% share 79.7%	2,766 +0.3% share 80.5%	2,759 +12.3% share 82.0%	2,458 +16.5% share 82.9%	2,110 +4.6% share 83.4%	2,017 +23.1% share 83.4%	1,638 -6.1% share 82.4%	1,745 +10.7% share 84.2%	1,577 +6.6% share 83.2%	1,480 share 83.8%	—
Product And Service Other	714 +8.0% share 20.3%	670 +10.4% share 19.5%	607 +19.8% share 18.0%	507 +8075.8% share 17.1%	6 -16.2% share 0.2%	7 +23.3% share 0.3%	6 +9.1% share 0.3%	6 -24.7% share 0.3%	7 -11.0% share 0.4%	8 share 0.5%	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: BRKR (Nasdaq), BRKRP (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Billerica, MA
SEC filer status: Large accelerated filer
SEC CIK: 1109354
Former names: BRUKER BIOSCIENCES CORP (until Feb 27, 2008); BRUKER DALTONICS INC (until Jul 2, 2003)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.